These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11433817

  • 1. Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.
    Doi Y, Kitaoka H.
    J Cardiol; 2001; 37 Suppl 1():133-8. PubMed ID: 11433817
    [Abstract] [Full Text] [Related]

  • 2. [Clinical features and significance of hypertrophic cardiomyopathy with atrial fibrillation].
    Samukawa M, Hasegawa K, Harada Y, Nakao M, Tadaoka S, Yoneda M, Fujiwara T, Nakamura T, Nezuo S, Sawayama T.
    J Cardiol; 1987 Sep; 17(3):465-74. PubMed ID: 3453843
    [Abstract] [Full Text] [Related]

  • 3. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.
    Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ.
    J Am Coll Cardiol; 1995 Nov 15; 26(6):1529-36. PubMed ID: 7594081
    [Abstract] [Full Text] [Related]

  • 4. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Yashiro B, Minami Y, Terajima Y, Hagiwara N.
    J Cardiol; 2014 Jun 15; 63(6):432-7. PubMed ID: 24280311
    [Abstract] [Full Text] [Related]

  • 5. P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy.
    Ozdemir O, Soylu M, Demir AD, Topaloglu S, Alyan O, Turhan H, Bicer A, Kutuk E.
    Int J Cardiol; 2004 Apr 15; 94(2-3):163-6. PubMed ID: 15093974
    [Abstract] [Full Text] [Related]

  • 6. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bunch TJ, Munger TM, Friedman PA, Asirvatham SJ, Brady PA, Cha YM, Rea RF, Shen WK, Powell BD, Ommen SR, Monahan KH, Haroldson JM, Packer DL.
    J Cardiovasc Electrophysiol; 2008 Oct 15; 19(10):1009-14. PubMed ID: 18479329
    [Abstract] [Full Text] [Related]

  • 7. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 8. The prognostic significance of exercise-induced atrial arrhythmias.
    Bunch TJ, Chandrasekaran K, Gersh BJ, Hammill SC, Hodge DO, Khan AH, Packer DL, Pellikka PA.
    J Am Coll Cardiol; 2004 Apr 07; 43(7):1236-40. PubMed ID: 15063436
    [Abstract] [Full Text] [Related]

  • 9. [Natural history of 82 patients with hypertrophic cardiomyopathy: follow-up for over ten years].
    Ishiwata S, Nishiyama S, Nakanishi S, Nishimura S, Yanagishita Y, Kato K, Seki A, Yamaguchi H.
    J Cardiol; 1991 Apr 07; 21(1):61-73. PubMed ID: 1817182
    [Abstract] [Full Text] [Related]

  • 10. Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy.
    Ogimoto A, Hamada M, Nakura J, Miki T, Hiwada K.
    J Hum Genet; 2002 Apr 07; 47(4):184-9. PubMed ID: 12166654
    [Abstract] [Full Text] [Related]

  • 11. [Natural course of hypertrophic cardiomyopathy: clinical, hemodynamic and echocardiographic features in the end stage].
    Suwa M, Hirota Y, Nakayama Y, Yoneda Y, Kawamura K.
    J Cardiol Suppl; 1987 Apr 07; 16():65-78. PubMed ID: 2978474
    [Abstract] [Full Text] [Related]

  • 12. Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Haruki S, Minami Y, Hagiwara N.
    Stroke; 2016 Apr 07; 47(4):936-42. PubMed ID: 26941260
    [Abstract] [Full Text] [Related]

  • 13. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.
    Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, Sheldon R, Dorian P, Newman D.
    Am Heart J; 2005 Mar 07; 149(3):489-96. PubMed ID: 15864238
    [Abstract] [Full Text] [Related]

  • 14. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K.
    J Heart Lung Transplant; 2006 Jan 07; 25(1):53-60. PubMed ID: 16399531
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK.
    J Am Coll Cardiol; 2010 Sep 07; 56(11):867-74. PubMed ID: 20688032
    [Abstract] [Full Text] [Related]

  • 16. Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy.
    Tian T, Wang Y, Sun K, Wang J, Zou Y, Zhang W, Bao J, Zhu L, Shen H, Hui R, Zhou X, Song L.
    Cardiology; 2013 Sep 07; 126(4):258-64. PubMed ID: 24157592
    [Abstract] [Full Text] [Related]

  • 17. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome.
    Richter B, Gwechenberger M, Socas A, Marx M, Gössinger HD.
    Am J Cardiol; 2008 Mar 15; 101(6):843-7. PubMed ID: 18328850
    [Abstract] [Full Text] [Related]

  • 18. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy.
    Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, Siu S, Ralph-Edwards A, Rakowski H.
    Circulation; 2005 Apr 26; 111(16):2033-41. PubMed ID: 15824202
    [Abstract] [Full Text] [Related]

  • 19. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, Lofiego C, Boriani G, Prandstraller D, Picchio FM, Branzi A, Rapezzi C.
    J Am Coll Cardiol; 2005 Oct 18; 46(8):1543-50. PubMed ID: 16226182
    [Abstract] [Full Text] [Related]

  • 20. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA.
    Europace; 2009 May 18; 11(5):643-9. PubMed ID: 19164362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.